Wearable Technologies for Pregnant Women with Type One Diabetes

Dawn Adams

Research output: Contribution to conferencePosterpeer-review


Type One Diabetes (T1D) pregnancies are high-risk. Pre-eclampsia, foetal malformation & mortality rates remain 2-5 times greater than for non-diabetic populations Access to wearable technologies has improved pregnancy outcomes by facilitating self-management and increasing time spent in the target glucose range of 3.5-7.8mmols/L.

NICE Pregnancy guidelines recommend physical activity to reduce the risks of high blood-pressure, weight gain and deep venous thromboembolism, while promoting mental well-being.

Available wearable technologies provide feedback on glucose variability and activity during pregnancy. Integrating this data may inform and support decisions improving self-management of T1D during pregnancy.
Original languageEnglish
Number of pages1
Publication statusPublished (in print/issue) - 28 Feb 2011
EventAll Ireland Maternity and Midwifery Festival 2020 - Croke Park, Dublin, Ireland
Duration: 11 Feb 202011 Feb 2020


ConferenceAll Ireland Maternity and Midwifery Festival 2020


Dive into the research topics of 'Wearable Technologies for Pregnant Women with Type One Diabetes'. Together they form a unique fingerprint.

Cite this